Report Categories
View AllRecent Articles
View All
Cadiz CDZI Q3 2025 Disappoints EPS 010 Below 009 Views
OpenAI Revenue Chief Signals Enterprise AI Adoption Has Hit a Critical Threshold
WESCO International WCC Drops 191 Key Support at 33429 20260518
Wordle 1795 Continues to Drive Engagement for NYTs Digital Subscriber Strategy
CBS Cancels The Late Show With Stephen Colbert Shifts LateNight Strategy With Comics Unleashed
India Bank Education Loans Surge 15 to 858 Lakh Crore in FY26 Driven by Rising Overseas Study Costs
Meta to Launch AI Subscription Service Trial Starting at 799 Per Month
UK Exports to US Plunge 25 After Trumps Liberation Day Tariffs
Chip Stocks Pare Recent Gains Oil Prices Slip on Mideast Deal Hopes
DHT Holdings Q1 2026 Earnings Strong EPS Beat Amid Tanker Market Strength
ABSI Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in AI Drug Discovery
SVM Q1 2026 Earnings Strong EPS Beat Highlights Silver and Cost Management Gains
CSTE Q1 2026 Earnings EPS Surpasses Estimates Despite Net Loss
HTFC Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance
Aptorum Group Limited APM Rises 296 as Stock Approaches Key Resistance Level
Venture Global VG Finds Footing Near Support Tests Key Resistance Levels
TH International THCH Edges Higher Consolidating Between Support and Resistance
CapsoVision Inc CV Gains 177 as Shares Test Key Resistance Near 723
Summer Cooling Costs Surge Amid Rising Electricity Prices and Heat Waves
SpaceX Postpones Starship Launch Amid Plans for Landmark Stock Market Debut
Qualcomm Stock Surges as Investors Bet on AI Device Expansion
Indonesia Stagflation Warning from Japanese Consumer Goods Firm
EON Resources Inc EONR Faces Selling Pressure as Shares Slide 65 Key Support Level in Focus
Cronos Group CRON Edges Higher as Cannabis Stock Tests Key Resistance
First Mid Bancshares Edges Lower Testing Support at 4386
Materialise NV MTLS Rallies 39 Key Levels in Focus After a Volatile Stretch
Sizzle Acquisition Corp II Rights SZZLR Trading at 016 Navigating a Narrow Range
Protalix BioTherapeutics PLX Rises 143 as Biotech Stock Tests Key Resistance